Meditera Tibbi Malzeme Sanayi ve Ticaret AS
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers breathing sytems products, including breathing circuits, breathing filters, catheter mounts, gas sampling lines, accessories, masks, and connectors. It also provides hospital products, such as barrier cream, surgical hand brushes for skin disinfection, hand and skin antisep… Read more
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) - Total Liabilities
Latest total liabilities as of September 2025: TL750.74 Million TRY
Based on the latest financial reports, Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has total liabilities worth TL750.74 Million TRY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Total Liabilities Trend (2018–2024)
This chart illustrates how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Competitors by Total Liabilities
The table below lists competitors of Meditera Tibbi Malzeme Sanayi ve Ticaret AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Big Tree Cloud Holdings Limited Ordinary Shares
NASDAQ:DSY
|
USA | $11.18 Million |
|
HAKI Safety A
ST:HAKI-A
|
Sweden | Skr745.00 Million |
|
Ezfly International Travel Agent Co. Ltd.
TWO:2734
|
Taiwan | NT$441.62 Million |
|
Guangdong Land Holdings Limited
PINK:KYBWF
|
USA | $31.63 Billion |
|
Health In Tech, Inc. Class A Common Stock
NASDAQ:HIT
|
USA | $5.60 Million |
|
TOP Engineering Co. Ltd
KQ:065130
|
Korea | ₩200.30 Billion |
Liability Composition Analysis (2018–2024)
This chart breaks down Meditera Tibbi Malzeme Sanayi ve Ticaret AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2024)
The table below shows the annual total liabilities of Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | TL575.09 Million | -3.60% |
| 2023-12-31 | TL596.54 Million | +180.84% |
| 2022-12-31 | TL212.41 Million | +41.76% |
| 2021-12-31 | TL149.84 Million | +20.32% |
| 2020-12-31 | TL124.53 Million | +32.87% |
| 2019-12-31 | TL93.72 Million | -1.71% |
| 2018-12-31 | TL95.36 Million | -- |